Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies
Vascular endothelial growth factor receptor 2 (VEGFR-2) is a crucial mediator of angiogenesis, playing a pivotal role in both normal physiological processes and cancer progression. Tumors harness VEGFR-2 signaling to promote abnormal blood vessel growth, which is a key step in the metastasis process...
Saved in:
| Main Authors: | Carolina S. Marques, Pedro Brandão, Anthony J. Burke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/29/22/5341 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Five-membered ring heterocyclic compounds as anticancer drug candidates
by: Arif Mermer, et al.
Published: (2025-04-01) -
Recent advances in (4 + 3) cycloaddition of allenes
by: Yanyan Que, et al.
Published: (2024-11-01) -
Synthetic approaches, emerging applications, and challenges of indole-based five-membered heterocycles in medicinal chemistry
by: M. Padmapriya, et al.
Published: (2025-03-01) -
Design, synthesis and bioactivity evaluation of phosphinanes as potential anticancer agents
by: Elżbieta Łastawiecka, et al.
Published: (2025-08-01) -
METHODS OF SYNTHESIS EIGHT-TELLURIUM-CONTAINING HETEROCYCLES WITH MORE HETEROATOMS
by: G. M. Abakarov
Published: (2016-08-01)